HRMY

Harmony Biosciences Holdings, Inc.

Pharmaceutical PreparationsNasdaqLarge accelerated filer

Total Trades

94

Buys

0

Sells

66

Largest Trade

N/A

Insiders

9

Institutional Funds

256

Inst. Value

$1M+

Activist Filings

20

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Dierks JeffreyCHIEF COMMERCIAL O…EXERCISE$100K–$500K12K$8.22Oct 4, 2022
Dierks JeffreyCHIEF COMMERCIAL O…EXERCISE$500K+29K$24.00Aug 23, 2022
Dierks JeffreyCHIEF COMMERCIAL O…SELL$1M+29K$47.00Aug 23, 2022
Jacobs John CPRESIDENT, CEOEXERCISE$100K–$500K40K$8.22Aug 16, 2022
Jacobs John CPRESIDENT, CEOSELL$1M+40K$51.07Aug 16, 2022
Wicki AndreasDirectorSELL$1M+579K$53.77Aug 11, 2022
Nielsen JackDirectorSELL$1M+250K$52.73Aug 9, 2022
Wicki AndreasDirectorSELL$1M+73K$52.73Aug 5, 2022
Nielsen JackDirectorSELL$1M+75K$55.22Aug 3, 2022
Nielsen JackDirectorSELL$1M+40K$55.19Jul 20, 2022
Nielsen JackDirectorSELL$100K–$500K6K$55.04Jul 16, 2022
Nielsen JackDirectorSELL$500K+11K$55.05Jul 12, 2022
Nielsen JackDirectorSELL$1M+301K$55.39Jul 7, 2022
Nielsen JackDirectorSELL$500K+15K$52.08Jul 1, 2022
Nielsen JackDirectorSELL$1M+100K$52.33Jun 28, 2022
Jacobs John CPresident, CEOEXERCISE$100K–$500K15K$8.22Jun 16, 2022
Jacobs John CPresident, CEOSELL$500K+15K$45.42Jun 16, 2022
Jacobs John CPresident, CEOSELL$1M+25K$44.18Jun 14, 2022
Jacobs John CPresident, CEOEXERCISE$100K–$500K25K$8.22Jun 14, 2022
Nielsen JackDirectorSELL$100K–$500K7K$52.19Apr 25, 2022
Nielsen JackDirectorSELL$1M+132K$52.30Apr 20, 2022
Nielsen JackDirectorSELL$1M+120K$51.07Apr 14, 2022
Nielsen JackDirectorSELL$500K+11K$50.17Apr 11, 2022
Nielsen JackDirectorSELL$1M+21K$50.24Apr 6, 2022
Dierks JeffreyChief Commercial O…EXERCISE$100K–$500K14K$24.00Apr 5, 2022
Dierks JeffreyChief Commercial O…SELL$500K+14K$49.63Apr 5, 2022
Nielsen JackDirectorSELL$1M+37K$50.21Apr 1, 2022
Nielsen JackDirectorSELL$1M+114K$50.66Mar 30, 2022
Nielsen JackDirectorSELL$1M+36K$50.16Mar 25, 2022
Nielsen JackDirectorSELL$500K+16K$50.08Mar 22, 2022
Jacobs John CPresident, CEOSELL$500K+15K$45.32Mar 18, 2022
Jacobs John CPresident, CEOEXERCISE$100K–$500K15K$8.22Mar 18, 2022
Jacobs John CPresident, CEOSELL$1M+25K$42.39Mar 16, 2022
Jacobs John CPresident, CEOEXERCISE$100K–$500K25K$8.22Mar 16, 2022
Wicki AndreasDirectorSELL$1M+286K$45.24Mar 12, 2022
Wicki AndreasDirectorSELL$1M+596K$40.62Mar 4, 2022
Dierks JeffreyChief Commercial O…SELL$500K+15K$40.01Mar 2, 2022
Dierks JeffreyChief Commercial O…EXERCISE$100K–$500K15K$18.85Mar 2, 2022
Dierks JeffreyChief Commercial O…SELL$100K–$500K9K$40.03Feb 18, 2022
Dierks JeffreyChief Commercial O…EXERCISE$100K–$500K4K$24.00Feb 18, 2022
Dierks JeffreyChief Commercial O…SELL$100K–$500K6K$40.37Jan 10, 2022
Dierks JeffreyChief Commercial O…EXERCISE$50K–$100K6K$8.22Jan 10, 2022
Jacobs John CPresident, CEOEXERCISE$100K–$500K29K$8.22Jan 5, 2022
Jacobs John CPresident, CEOSELL$1M+29K$45.16Jan 5, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

FMR LLC

SC 13G/A · Feb 5, 2026

5.4%

3.1M shares

Valor IV Pharma Holdings, LLC

SC 13G/A · Nov 14, 2025

0.0%

0 shares

FMR LLC

SC 13G/A · Nov 5, 2025

6.7%

3.8M shares

BlackRock, Inc.

SC 13G/A · Apr 29, 2025

10.1%

5.8M shares

Valor IV Pharma Holdings, LLC

SC 13G/A · Feb 12, 2025

11.6%

6.6M shares

Marshman Fund Trust II

SC 13G/A · Feb 10, 2025

10.6%

6.1M shares

BlackRock, Inc.

SC 13G/A · Feb 5, 2025

12.2%

7.0M shares

The Vanguard Group

SC 13G/A · Jan 31, 2025

8.3%

4.7M shares

Valor IV Pharma Holdings, LLC

SC 13G/A · Feb 14, 2024

19.2%

11.2M shares

The Vanguard Group - 23-1945930

SC 13G/A · Feb 13, 2024

6.3%

3.7M shares

BlackRock, Inc.

SC 13G/A · Jan 24, 2024

10.2%

6.0M shares

BlackRock, Inc.

SC 13G/A · Oct 6, 2023

10.2%

6.1M shares

3.6%

2.1M shares

Vivo Capital VIII, LLC

SC 13G/A · Feb 13, 2023

4.3%

2.6M shares

Valor IV Pharma Holdings, LLC

SC 13G/A · Feb 13, 2023

18.9%

11.2M shares

BlackRock, Inc.

SC 13G/A · Feb 3, 2023

8.2%

4.9M shares

4.7%

2.7M shares

Vivo Capital VIII, LLC

SC 13G/A · Feb 11, 2022

7.4%

4.3M shares

7.8%

4.5M shares

Valor IV Pharma Holdings, LLC

SC 13G/A · Feb 10, 2022

19.2%

11.2M shares

View on Google Finance →